Baseline plasma proinsulin response to glucose for predicting therapeutic response to otelixizumab in recent-onset type 1 diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Baseline plasma proinsulin response to glucose for predicting therapeutic response to otelixizumab in recent-onset type 1 diabetes

Published:2023-11 Issue: Volume:205 Page:110974
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Desouter Aster K.^ORCID,Keymeulen Bart^ORCID,Demeester Simke,Van de Velde Ursule,De Pauw Pieter,Van Dalem Annelien,Lapauw Bruno^ORCID,De Block Christophe,Gillard Pieter^ORCID,Pipeleers Daniel G.^ORCID,Gorus Frans K.

Funder

Juvenile Diabetes Research Foundation United States of America

Agentschap voor Innovatie door Wetenschap en Technologie

Vrije Universiteit Brussel

Juvenile Diabetes Research Foundation International

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference43 articles.

1. Restoring a functional beta-cell mass in diabetes;Pipeleers;Diabetes Obes Metab,2008

2. The compelling case for anti-CD3 in type 1 diabetes;Skyler;Diabetes,2013

3. Changing the landscape for type 1 diabetes: the first step to prevention;Dayan;Lancet,2019

4. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus;Herold;N Engl J Med,2002

5. A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes;Herold;Diabetes,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP